Drug Development

Articles

The use of artificial intelligence creates growth opportunities in novel therapeutics development by leveraging multi-sourced data, according to experts at research and consulting firm Frost & Sullivan.

AI Enables Smart Drug Discovery Solutions

The company’s biosimiliar to Roche’s Avastin (bevacizumab) received a positive opinion for marketing authorization from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

Pfizer Receives Positive CHMP Opinion for Avastin Biosimilar

Avacta Group and LC Chem Life Sciences have entered into a multi-target collaboration and development agreement.

Avacta and LG Chem Life Sciences Enter Multi-Target Collaboration and Development Agreement

FDA has withdrawn the proposed rule that would have allowed generic-drug makers to independently update and distribute new safety information in drug labels.

FDA Looks to Modernize Generic Drug Labels

FDA has approved Truxima (rituximab-abbs), a biosimilar to Roche’s anti-cancer biologic, Rituxan (rituximab).

FDA Approves Celltrion and Teva’s Biosimilar to Rituxan

GSK and TESARO have entered into a definitive agreement concerning GSK's acquisition of TESARO for an aggregate cash consideration worth approximately $5.1 billion.

GSK and TESARO Reach Acquisition Agreement

AbbVie will grant Pfizer license to launch a biosimilar to AbbVie’s Humira worldwide.

Pfizer Gets Global Patent License for AbbVie’s Humira

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Transdermal patch design, materials, and manufacturing variables, as well as drug formulation and interactions between the API and the adhesive, can affect adhesion and drug delivery. 

Developing and Manufacturing Transdermal Patches

Virpax’s Patch-in-a-Can technology delivers pain medication using a metered-dose spray film.

Spray Film Provides Alternative to Patches

Drug and adhesive formulation are crucial to the development of microneedle patches for pharmaceutical transdermal delivery systems. 

Formulation and Drug Delivery